Skip to main content
. Author manuscript; available in PMC: 2011 Mar 19.
Published in final edited form as: Chem Biol Interact. 2009 Oct 12;184(1-2):21–25. doi: 10.1016/j.cbi.2009.10.002

Table 2. Association of clinical outcomes with microRNA-181a expression in 187 patients with CN-AML <60 years old (22).

Outcome Higher expression Lower expression P
Compete remission 84% 72% 0.07
5-year Disease-free survival 43% 18% 0.05
5-year Survival 48% 19% 0.01

For descriptive purposes, the percentages are reported for patients dichotomized at the median, but miR-181a expression was analyzed statistically as a continuous variable.